CorMedix (CRMD) Operating Expenses (2010 - 2026)
CorMedix (CRMD) posted Operating Expenses of $48.2 million for Q4 2025, up 15.45% sequentially from $41.7 million in Q3 2025, and up 181.79% YoY from $17.1 million in Q4 2024.
CorMedix (CRMD) Operating Expenses (2010 - 2026) Analysis & Trends
CorMedix has reported Operating Expenses for 15 years, with the latest figure at $48.2 million in Q4 2025.
- Quarterly Operating Expenses rose 181.79% year-over-year to $48.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $125.6 million (up 100.53% YoY) and the FY2025 annual result came in at $125.6 million, up 100.53% from the prior year.
- Operating Expenses improved to $48.2 million in Q4 2025 per CRMD's latest filing, from $41.7 million in the prior quarter.
- Over five years, Operating Expenses peaked at $48.2 million in Q4 2025 and troughed at $5.9 million in Q2 2021.
- A 5-year average of $14.9 million and a median of $11.4 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2021 and 2025: Operating Expenses plunged 34.11% in 2021, then jumped 196.9% in 2025.
- Over 5 years, Operating Expenses stood at $7.8 million in 2021, then advanced by 8.09% to $8.4 million in 2022, then soared by 86.12% to $15.7 million in 2023, then climbed by 9.12% to $17.1 million in 2024, then surged by 181.79% to $48.2 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $48.2 million, $41.7 million, and $18.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | 34.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.22 Mn |
| Dec 31, 2025 | 48.18 Mn |
| Sep 30, 2025 | 41.73 Mn |
| Jun 30, 2025 | 18.33 Mn |
| Mar 31, 2025 | 17.36 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Sep 30, 2024 | 14.06 Mn |
| Jun 30, 2024 | 15.60 Mn |
| Mar 31, 2024 | 15.89 Mn |
| Dec 31, 2023 | 15.67 Mn |
| Sep 30, 2023 | 10.47 Mn |
| Jun 30, 2023 | 11.80 Mn |
| Mar 31, 2023 | 11.02 Mn |
| Dec 31, 2022 | 8.42 Mn |
| Sep 30, 2022 | 6.97 Mn |
| Jun 30, 2022 | 8.26 Mn |
| Mar 31, 2022 | 7.04 Mn |
| Dec 31, 2021 | 7.79 Mn |
| Sep 30, 2021 | 8.58 Mn |
| Jun 30, 2021 | 5.88 Mn |